Apetoh et al. reported that activation of tumor antigen-specific T cell responses involve the secretion of high-mobility-group box 1 (HMGB1) alarmin protein from dying tumor cells and the action of HMGB1 on Toll-like receptor 4 (TLR4)-expressing dendritic cells [4]. The gene discussed is HMGB1; the disease is neoplasm.